Be cautious about self-experimentation without medical oversight due to unknown risks (e.g., contamination, cancer promotion) and unregulated sourcing
1 2D Structure 2 Identification 2.1 Computed Descriptors 2.1.1 IUPAC Name (2S)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-[(2-amino-2-methylpropanoyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-3-phenylpropanoyl]amino]hexanamide 2.1.2 InChI InChI=1S/C38H49N9O5/c1-38(2,41)37(52)47-32(21-28-22-42-23-43-28)36(51)46-31(20-25-15-16-26-12-6-7-13-27(26)18-25)35(50)45-30(19-24-10-4-3-5-11-24)34(49)44-29(33(40)48)14-8-9-17-39/h3-7,10-13,15-16,18,22-23,29-32H,8-9,14,17,19-21,39,41H2,1-2H3,(H2,40,48)(H,42,43)(H,44,49)(H,45,50)(H,46,51)(H,47,52)/t29-,30+,31+,32-/m0/s1 2.1.3 InChI Key NEHWBYHLYZGBNO-BVEPWEIPSA-N 2.1.4 Canonical SMILES CC(C)(C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC3=CC=CC=C3C=C2)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCCCN)C(=O)N)N 2.1.5 Isomeric SMILES CC(C)(C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC2=CC3=CC=CC=C3C=C2)C(=O)N[C@H](CC4=CC=CC=C4)C(=O)N[C@@H](CCCCN)C(=O)N)N 2.2 Other Identifiers 2.2.1 UNII 2.3 Synonyms 2.3.1 MeSH Synonyms 1
Accordingly, better designed and more rigorous research and clinical trials are required before they can be established as a therapeutic alternative and further studies would also be necessary to corroborate the use of these antioxidants administered as a co-treatment with the current medications
When taurine levels are low, bile acid conjugation shifts toward glycine conjugation, which produces less efficient bile salt micelles and impairs toxin excretion
Not for human or veterinary use Not intended for food, cosmetic, or household applications Not intended to diagnose, treat, cure, or prevent any disease To be handled only by qualified research professionals By purchasing this product, the buyer acknowledges that the material will be used solely within a lawful laboratory research environment and in accordance with all applicable laws and regulations
Glutathione l cht chng oxy ha ni sinh, ng vai tr trung tm trong h thng kh - oxy ha ca c th, gp phn trung ha cc gc t do v tham gia vo qu trnh gii c ti gan
